Boehringer Ingelheim gets USFDA nod for high-concentration, citrate-free formulation of Cyltezo to treat multiple chronic inflammatory diseases Ruchika Sharma2 May 2024 11:30 AM ISTThe high-concentration formulation (100 mg/mL), which is now available as a pre-filled syringe or pre-filled autoinjector.
Boehringer unveils 81 percent discounted biosimilar of AbbVie Humira Ruchika Sharma4 Oct 2023 3:30 PM ISTUntil recently, Humira was the world's biggest-selling prescription drug. It had sales of USD 21.2 billion in 2022.
Boehringer Ingelheim Cyltezo gets USFDA nod as 1st iterchangeable biosimilar with Humira Ruchika Sharma17 Oct 2021 11:00 AM ISTRidgefield: Boehringer Ingelheim has recently announced that the U.S. Food and Drug Administration (USFDA) has approved the supplemental Biologics...
